French Study finds cancer risk associated with GM corn
As Monsanto and DuPont pour money into the campaign against Prop 37, which would require labelling of GMO foods, a French study finds a cancer risk associated with consumption of Roundup-Ready GM corn.
Reuter’s covers the story, beginning by citing “criticism from other experts.” To pretend to be a news agency, however, the organization includes this:
France’s Jose Bove, vice-chairman of the European Parliament’s commission for agriculture and known as an opponent of GM, called for an immediate suspension of all EU cultivation and import authorizations of GM crops.
“This study finally shows we are right and that it is urgent to quickly review all GMO evaluation processes,” he said in a statement. “National and European food security agencies must carry out new studies financed by public funding to guarantee healthy food for European consumers.”
An English press release on the study is here: http://www.criigen.org/SiteEn/index.php?option=com_content&task=view&id=366&Itemid=130
Another article on the study, here — http://www.heraldonline.com/2012/09/19/4274523/first-peer-reviewed-lifetime-feeding.html — points out that the “medium” dosage in the experiment corresponded to the United States “safe” limit. Great.
Three groups were given Roundup in their drinking water, at three different levels consistent with exposure through the food chain from crops sprayed with the weedkiller: the mid level corresponded to the maximum level permitted in the US in some GM feed; the lowest corresponded to contamination found in some tap waters. Three groups were fed diets which contained different proportions of NK603 – 11%, 22% and 33%. Three groups were given both Roundup and NK603 at the same three dosages. The final control group was fed an equivalent diet with no Roundup or NK603 but containing 33% of equivalent non-GM maize.
Researchers found that NK603 and Roundup both caused similar damage to the rats’ health whether they were consumed on their own or together. Females developed fatal mammary tumours and pituitary disorders. Males suffered liver damage, developed kidney and skin tumors and experienced problems with their digestive system. The team also identified a “threshold effect” where even the lowest doses were associated with severe health problems.